Therefore, according to their results, it can be stated that hsCRP has incremental prognostic value for the risk of death or HF, independent of NTproBNP and hs troponin T. The clinical decline of patients with ACHD was anticipated by elevated hsCRP concentrations, which were increased before symptoms of HF or death [123]. This evidence concerns the gene NPPB and hydrops fetalis.